Abstract

Physiologically based pharmacokinetic (PBPK) models are useful in risk assessment as a scientifically supportable way for conducting extrapolations, thereby reducing uncertainty. PBPK models’ applications in risk assessment include route-to-route extrapolation, extrapolation across exposure patterns, interspecies extrapolation, and comparing sensitive subpopulations to the general population. This chapter provides an overview of the basics of risk assessment, discusses an approach for how to evaluate PBPK models for potential use in risk assessment, and provides brief summaries of examples of modern applications of PBPK models in risk assessment.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call